Medly Therapeutics
PrivateLast Round
Grant
Feb 18, 2025
Total Funding Raised
$1.35M
Company Overview
Medly Therapeutics is a digital health company that provides an AI-powered, clinically validated platform for the remote management of chronic conditions, including heart failure.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Medical Devices, Patient Engagement, Telemedicine, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Medly Therapeutics Comparables
Compare Medly Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SeamlessMD | 76% | |
| Veta Health | 76% | |
| CareSimple | 73% | |
Medly Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Feb 18, 2025 |
Medly Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Canadian Institutes of Health Research | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 18, 2025
$1.35M grant from Canadian Institutes of Health Research
Medly Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Medly Therapeutics's valuation, stock price, and market status.